🎉 M&A multiples are live!
Check it out!

Journey Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Journey Medical and similar public comparables like Vivoryon Therapeutics, Pharming, and Galapagos.

Journey Medical Overview

About Journey Medical

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.


Founded

2014

HQ

United States of America
Employees

41

Financials

LTM Revenue $60.3M

LTM EBITDA $3.4M

EV

$148M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Journey Medical Financials

Journey Medical has a last 12-month revenue of $60.3M and a last 12-month EBITDA of $3.4M.

In the most recent fiscal year, Journey Medical achieved revenue of $56.1M and an EBITDA of -$8.4M.

Journey Medical expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Journey Medical valuation multiples based on analyst estimates

Journey Medical P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $79.2M $56.1M XXX XXX XXX
Gross Profit $42.9M $52.5M XXX XXX XXX
Gross Margin 54% 94% XXX XXX XXX
EBITDA $1.9M -$8.4M XXX XXX XXX
EBITDA Margin 2% -15% XXX XXX XXX
Net Profit -$29.6M -$3.9M XXX XXX XXX
Net Margin -37% -7% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Journey Medical Stock Performance

As of April 15, 2025, Journey Medical's stock price is $6.

Journey Medical has current market cap of $143M, and EV of $148M.

See Journey Medical trading valuation data

Journey Medical Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$148M $143M XXX XXX XXX XXX $-0.62

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Journey Medical Valuation Multiples

As of April 15, 2025, Journey Medical has market cap of $143M and EV of $148M.

Journey Medical's trades at 2.5x LTM EV/Revenue multiple, and 43.2x LTM EBITDA.

Analysts estimate Journey Medical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Journey Medical and 10K+ public comps

Journey Medical Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $148M XXX XXX XXX
EV/Revenue 2.6x XXX XXX XXX
EV/EBITDA -17.7x XXX XXX XXX
P/E -9.8x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -6.1x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Journey Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Journey Medical Valuation Multiples

Journey Medical's NTM/LTM revenue growth is 33%

Journey Medical's revenue per employee for the last fiscal year averaged $1.4M, while opex per employee averaged $1.3M for the same period.

Over next 12 months, Journey Medical's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Journey Medical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Journey Medical and other 10K+ public comps

Journey Medical Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -29% XXX XXX XXX XXX
EBITDA Margin -15% XXX XXX XXX XXX
EBITDA Growth -537% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 18% XXX XXX XXX XXX
Revenue per Employee $1.4M XXX XXX XXX XXX
Opex per Employee $1.3M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 18% XXX XXX XXX XXX
Opex to Revenue 95% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Journey Medical Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Journey Medical M&A and Investment Activity

Journey Medical acquired  XXX companies to date.

Last acquisition by Journey Medical was  XXXXXXXX, XXXXX XXXXX XXXXXX . Journey Medical acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Journey Medical

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Journey Medical

When was Journey Medical founded? Journey Medical was founded in 2014.
Where is Journey Medical headquartered? Journey Medical is headquartered in United States of America.
How many employees does Journey Medical have? As of today, Journey Medical has 41 employees.
Who is the CEO of Journey Medical? Journey Medical's CEO is Mr. Claude Maraoui.
Is Journey Medical publicy listed? Yes, Journey Medical is a public company listed on NAS.
What is the stock symbol of Journey Medical? Journey Medical trades under DERM ticker.
When did Journey Medical go public? Journey Medical went public in 2021.
Who are competitors of Journey Medical? Similar companies to Journey Medical include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Journey Medical? Journey Medical's current market cap is $143M
What is the current revenue of Journey Medical? Journey Medical's last 12-month revenue is $60.3M.
What is the current EBITDA of Journey Medical? Journey Medical's last 12-month EBITDA is $3.4M.
What is the current EV/Revenue multiple of Journey Medical? Current revenue multiple of Journey Medical is 2.5x.
What is the current EV/EBITDA multiple of Journey Medical? Current EBITDA multiple of Journey Medical is 43.2x.
What is the current revenue growth of Journey Medical? Journey Medical revenue growth between 2023 and 2024 was -29%.
Is Journey Medical profitable? Yes, Journey Medical is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.